| __timestamp | Soleno Therapeutics, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2242216 | 45967000 |
| Thursday, January 1, 2015 | 4536244 | 114737000 |
| Friday, January 1, 2016 | 5184803 | 183204000 |
| Sunday, January 1, 2017 | 3068742 | 231644000 |
| Monday, January 1, 2018 | 7178000 | 293998000 |
| Tuesday, January 1, 2019 | 16267000 | 357355000 |
| Wednesday, January 1, 2020 | 23191000 | 412084000 |
| Friday, January 1, 2021 | 21453000 | 497153000 |
| Saturday, January 1, 2022 | 15265000 | 705789000 |
| Sunday, January 1, 2023 | 25189000 | 648449000 |
Data in motion
In the competitive world of biotechnology, innovation is the lifeblood of success. Ultragenyx Pharmaceutical Inc. and Soleno Therapeutics, Inc. are two companies that exemplify this drive. Over the past decade, Ultragenyx has consistently outpaced Soleno in research and development (R&D) spending, investing nearly 30 times more on average. In 2022, Ultragenyx's R&D expenses peaked at approximately 705 million, a staggering 3600% increase from 2014. Meanwhile, Soleno's investment, though more modest, has shown a steady upward trend, culminating in a 2023 expenditure of around 25 million, marking a 1000% rise since 2014. This data highlights the varying scales and strategies of innovation investment in the biotech sector, with Ultragenyx leading the charge in financial commitment. As these companies continue to innovate, their R&D investments will likely play a crucial role in shaping their future successes.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Soleno Therapeutics, Inc.
United Therapeutics Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Summit Therapeutics Inc. vs Soleno Therapeutics, Inc.
Pharming Group N.V. vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Lantheus Holdings, Inc. vs Ultragenyx Pharmaceutical Inc.
Research and Development Expenses Breakdown: Verona Pharma plc vs Ultragenyx Pharmaceutical Inc.
Amneal Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Ultragenyx Pharmaceutical Inc. vs HUTCHMED (China) Limited
R&D Insights: How Apellis Pharmaceuticals, Inc. and Soleno Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Soleno Therapeutics, Inc. vs Travere Therapeutics, Inc.
Soleno Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending